Clinical Research Directory

Participants eligible for inclusion in this Study must meet all of the following criteria: * Male or female, age \> 18 years * Hepatocellular carcinoma treated with systemic treatment during the disease course * Histological confirmation of HCC within one year of the start of systemic treatment OR the availability of an MRI of the liver within 6 months of the start of systemic treatment * Left-over tissue from previous diagnostic biopsy available * Ability to sign informed consent for secondary use of archival tissue and data collection for study-specific research for patients who are alive and that have not yet reached a 5-year follow-up period. Participants eligible for this Study must not meet any of the following criteria: * Hepatocellular carcinoma not treated systemically * Other malignancies of the liver, including cholangiocarcinoma